APA citiranje

KALRA, N., ASHAI, A., XI, L., ZHANG, J., AVITAL, I., RAFFELD, M., & HASSAN, R. (2012). Patients with peritoneal mesothelioma lack epidermal growth factor receptor tyrosine kinase mutations that would make them sensitive to tyrosine kinase inhibitors. Oncol Rep.

Citação norma Chicago

KALRA, NEETU, ALI ASHAI, LIQIANG XI, JINGLI ZHANG, ITZHAK AVITAL, MARK RAFFELD, and RAFFIT HASSAN. "Patients With Peritoneal Mesothelioma Lack Epidermal Growth Factor Receptor Tyrosine Kinase Mutations That Would Make Them Sensitive to Tyrosine Kinase Inhibitors." Oncol Rep 2012.

MLA citiranje

KALRA, NEETU, et al. "Patients With Peritoneal Mesothelioma Lack Epidermal Growth Factor Receptor Tyrosine Kinase Mutations That Would Make Them Sensitive to Tyrosine Kinase Inhibitors." Oncol Rep 2012.